Archive 1995–2023
2020, volume 36, issue 3
edytorial
Editorial
Janusz Rybakowski
Farmakoterapia w Psychiatrii i Neurologii 2020, 36 (3), 173-176
Review article
High dose aripiprazole – clinical use
Andrzej Juryk, Dominika Dudek
Farmakoterapia w Psychiatrii i Neurologii 2020, 36 (3), 177-185
Review article
MDMA – hopes and fears associated with therapeutic use in mental disorders
Kamil Kozera, Lena Cichoń, Krzysztof M. Wilczyński, Małgorzata Janas-Kozik
Farmakoterapia w Psychiatrii i Neurologii 2020, 36 (3), 187-204
Review article
Current state of knowledge on the use of medical marijuana in some neurological diseases
Katarzyna Ziętal, Ilona Joniec-Maciejak, Dagmara Mirowska-Guzel
Farmakoterapia w Psychiatrii i Neurologii 2020, 36 (3), 205-225
Review article
Hypersexuality and pharmacological treatment options
Beata Kocyan, Anna Knapik, Martyna Kozłowska, Ewa Martyniak, Grzegorz Brożek, Marek Krzystanek
Farmakoterapia w Psychiatrii i Neurologii 2020, 36 (3), 227-237
Review article
Genetic and pharmacogenetic counselling in psychiatric practice
Joanna M. Pawlak, Joanna W. Twarowska-Hauser
Farmakoterapia w Psychiatrii i Neurologii 2020, 36 (3), 239-249